As we begin 2025, I wanted to take the opportunity to recap on the progress we made in 2024 and key upcoming catalysts including our planned entrance into the multi-billion dollar U.S. market. 2024 ...

Sam Finn, a senior research associate at Zymo Research working with the Oncology Diagnostic Team, helped to host this interactive game booth at the “BioFestival” on Tuesday.

BETHESDA, Md., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the ...

CRANBROOK, BC / ACCESS Newswire / February 10, 2025 / Eagle Plains Resources Ltd. (TSX-V:EPL) ('Eagle Plains') is pleased to announce it has entered into a non- ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Gain Therapeutics (GANX) provided a letter to shareholders from the Company’s President and CEO, Gene Mack, which read in part,”With 2025 ...

On a late-summer day in 1856, a letter carrier stepped from a mail coach in front of a three-story townhouse in Mayfair, in ...

On the eve of Donald Trump's inauguration, the US Department of Health banned the financing and activities of the EcoHealth ...

It wasn’t a stretch to predict that the strict abortion bans in states such as Texas, Louisiana, Oklahoma and Arkansas would have demographic effects — driving residents out of those ...

Typically, you don’t have to write a cover letter before attending a candlelit dinner. But there are some eerie emotional ...

MMJ is currently engaged in litigation with the Drug Enforcement Administration (DEA). The company contends that the DEA has ...